BridgeMD
Compares treatment options for Socket Preservation
Official title Post Extraction Changes Following Ridge Preservation Using Allogenis Dentin Vs Autogenous Partially Demineralized Dentin
ClinicalTrials.gov ID: NCT06477887
What this study is testing
What is Allogeneic Dentin Matrix?
Allogeneic Dentin Matrix is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for socket preservation.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Research question: In patients with unrestorable anterior teeth, will the use of allogenic dentin matrix be more effective than autogenous partially demineralized dentine matrix (APDDM) in reducing hard tissue changes after post-extraction ridge preservation in the aesthetic zone? After enrolment, periodontal and radiographic examinations will be conducted, and patients with badly unrestorable teeth in the aesthetic zone will be identified.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60. Healthy volunteers may be eligible.
You may be able to join if
- Patients with good health status (ASA-1, ASA-2).
- Adult patients over 18 years old.
- Patients with non-restorable teeth in the aesthetic zone for periodontal, carious, or traumatic reasons.
- Extraction socket with no more than 50% buccal bone loss.
- Patients accept a 6-month follow-up period (cooperative patients).
You likely can't join if
- Patients reporting systemic conditions that may compromise healing (e.g., uncontrolled diabetes).
- Patients with poor maintenance of oral hygiene.
- Pregnancy.
- Smokers.
- Patients taking any medications that could compromise healing.
See the full eligibility criteria
- Patients with good health status (ASA-1, ASA-2).
- Adult patients over 18 years old.
- Patients with non-restorable teeth in the aesthetic zone for periodontal, carious, or traumatic reasons.
- Extraction socket with no more than 50% buccal bone loss.
- Patients accept a 6-month follow-up period (cooperative patients).
- Patients provide informed consent.
- Patients reporting systemic conditions that may compromise healing (e.g., uncontrolled diabetes).
- Patients with poor maintenance of oral hygiene.
- Pregnancy.
- Smokers.
- Patients taking any medications that could compromise healing.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Cairo, Elmanil, Egypt, 4240101, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Cairo, Elmanil, Egypt, 4240101, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.